InSilicoTrials Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom

Launch of Ground-Breaking Toward Good Simulation Practice Book to Set New Standards in Biomedical Simulation

About the editors

Marco Viceconti has significantly contributed to in silico medicine, introducing the concept with the first European research roadmap in 2006 and founding the VPH Institute to coordinate the research community. He also established the Avicenna Alliance, advocating for the biomedical industry in this field, and led the Insigneo Institute for in silico Medicine for seven years. Recognized as a fellow of the UK Royal Academy of Engineering and a member of the World Council of Biomechanics, Viceconti's work, including 368 papers with an H-index of 52, has earned him the Huiskes Medal for Biomechanics in 2021.

Luca Emili is the founder and CEO of InSilicoTrials Technologies, a platform facilitating the use of modeling and simulation in healthcare and life sciences. Prior to this, he was the CEO of Emaze, a cybersecurity firm that specialized in automated security analysis for complex networks. He is actively involved in several advisory roles, (Cloud Security Consultative Group at EMA, Co-chair of Avicenna Alliance's Good Simulation Practice (GSP) Task Force and member of the committee for the adoption of In Silico Medicine of the Italian Ministry of Health.

Photo - https://mma.prnewswire.com/media/2353500/InSilicoTrials.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/launch-of-ground-breaking-toward-good-simulation-practice-book-to-set-new-standards-in-biomedical-simulation-302078453.html